
<!DOCTYPE html>
<html>
<meta charset="UTF-8">
<head>
  <title>Topic 15 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 15 - 15 Topics</title>

<style>
table {
  font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #ddd;
  padding: 8px;
}

tr:nth-child(even){background-color: #f2f2f2;}

tr:hover {background-color: #ddd;}

th {
  padding-top: 12px;
  padding-bottom: 12px;
  text-align: left;
  background-color: #0099FF;
  color: white;
}
</style>

</head>
<body>
<h2>Topic 15 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 15 - 15 Topics</h2>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>cite ad</th>
      <th>title</th>
      <th>authors</th>
      <th>publish year</th>
      <th>publish time</th>
      <th>dataset</th>
      <th>abstract mentions covid</th>
      <th>pmcid</th>
      <th>pubmed id</th>
      <th>doi</th>
      <th>cord uid</th>
      <th>topic weight</th>
      <th>Similarity scispacy</th>
      <th>Similarity specter</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th id="la9svzml";>1</th>
      <td>Strohl_2017</td>
      <td>Current progress in innovative engineered antibodies</td>
      <td>Strohl, William R.</td>
      <td>2017</td>
      <td>2017-08-18</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777977" target="_blank">PMC5777977</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28822103.0" target="_blank">28822103.0</a></td>
      <td><a href="https://doi.org/10.1007/s13238-017-0457-8" target="_blank">10.1007/s13238-017-0457-8</a></td>
      <td>la9svzml</td>
      <td>0.555735</td>
      <td><a href="Topic_15.html#s6x0igia">Dove_2004</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="zghh0zbd";>2</th>
      <td>Rajeshkumar_2020</td>
      <td>Fatal toxicity of chloroquine or hydroxychloroquine with metformin in mice</td>
      <td>N.V Rajeshkumar; Shinichi Yabuuchi; Shweta G. Pai; Anirban Maitra; Manuel Hidalgo; Chi V. Dang</td>
      <td>2020</td>
      <td>2020-04-04</td>
      <td>BioRxiv</td>
      <td>Y</td>
      <td></td>
      <td></td>
      <td><a href="https://doi.org/10.1101/2020.03.31.018556" target="_blank">10.1101/2020.03.31.018556</a></td>
      <td>zghh0zbd</td>
      <td>0.553316</td>
      <td><a href="Topic_01.html#8kkihn51">Ekins_2015</a>, <a href="Topic_01.html#9oj6m3df">Pastuch-Gawołek_2019</a>, <a href="Topic_02.html#sasijnks">van_Boven_2008</a></td>
      <td><a href="Topic_03.html#xc4bxin4">Rolain_2007</a></td>
    </tr>
    <tr>
      <th id="mtmfh3uy";>3</th>
      <td>Aslesh_2018</td>
      <td>Skipping Multiple Exons to Treat DMD—Promises and Challenges</td>
      <td>Aslesh, Tejal; Maruyama, Rika; Yokota, Toshifumi</td>
      <td>2018</td>
      <td>2018-01-02</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874658" target="_blank">PMC5874658</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/29301272.0" target="_blank">29301272.0</a></td>
      <td><a href="https://doi.org/10.3390/biomedicines6010001" target="_blank">10.3390/biomedicines6010001</a></td>
      <td>mtmfh3uy</td>
      <td>0.461885</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="s30p3a23";>4</th>
      <td>Brouillet_2010</td>
      <td>Co-lethality studied as an asset against viral drug escape: the HIV protease case</td>
      <td>Brouillet, Sophie; Valere, Thomas; Ollivier, Emmanuelle; Marsan, Laurent; Vanet, Anne</td>
      <td>2010</td>
      <td>2010-06-17</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898770" target="_blank">PMC2898770</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/20565756.0" target="_blank">20565756.0</a></td>
      <td><a href="https://doi.org/10.1186/1745-6150-5-40" target="_blank">10.1186/1745-6150-5-40</a></td>
      <td>s30p3a23</td>
      <td>0.458305</td>
      <td></td>
      <td><a href="Topic_08.html#qhhdjgeq">Zhu_X_2015</a></td>
    </tr>
    <tr>
      <th id="cyjz29ot";>5</th>
      <td>Reichert_2006</td>
      <td>Anti-infective monoclonal antibodies: perils and promise of development</td>
      <td>Reichert, Janice M.; Dewitz, Matthew C.</td>
      <td>2006</td>
      <td>2006-01-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097328" target="_blank">PMC7097328</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/16518372.0" target="_blank">16518372.0</a></td>
      <td><a href="https://doi.org/10.1038/nrd1987" target="_blank">10.1038/nrd1987</a></td>
      <td>cyjz29ot</td>
      <td>0.421188</td>
      <td><a href="Topic_15.html#s6x0igia">Dove_2004</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="c7av3xql";>6</th>
      <td>Thomas_2010</td>
      <td>Receptor mimicry as novel therapeutic treatment for biothreat agents</td>
      <td>Thomas, Richard J</td>
      <td>2010</td>
      <td>2010-01-01</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035151" target="_blank">PMC3035151</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21327124.0" target="_blank">21327124.0</a></td>
      <td><a href="https://doi.org/10.4161/bbug.1.1.10049" target="_blank">10.4161/bbug.1.1.10049</a></td>
      <td>c7av3xql</td>
      <td>0.420714</td>
      <td></td>
      <td><a href="Topic_02.html#gxbrgy6g">Lee_C_2019</a>, <a href="Topic_03.html#eamctnik">Opsenica_2011</a></td>
    </tr>
    <tr>
      <th id="vk7dsy4r";>7</th>
      <td>Riaño-Umbarila_2019</td>
      <td>Generation of a Broadly Cross-Neutralizing Antibody Fragment against Several Mexican Scorpion Venoms</td>
      <td>Riaño-Umbarila, Lidia; Gómez-Ramírez, Ilse V.; Ledezma-Candanoza, Luis M.; Olamendi-Portugal, Timoteo; Rodríguez-Rodríguez, Everardo Remi; Fernández-Taboada, Guillermo; Possani, Lourival D.; Becerril, Baltazar</td>
      <td>2019</td>
      <td>2019-01-10</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356842" target="_blank">PMC6356842</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/30634620.0" target="_blank">30634620.0</a></td>
      <td><a href="https://doi.org/10.3390/toxins11010032" target="_blank">10.3390/toxins11010032</a></td>
      <td>vk7dsy4r</td>
      <td>0.418238</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="s6x0igia";>8</th>
      <td>Dove_2004</td>
      <td>Making prevention pay</td>
      <td>Dove, Alan</td>
      <td>2004</td>
      <td>2004-01-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097210" target="_blank">PMC7097210</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/15060549.0" target="_blank">15060549.0</a></td>
      <td><a href="https://doi.org/10.1038/nbt0404-387" target="_blank">10.1038/nbt0404-387</a></td>
      <td>s6x0igia</td>
      <td>0.411178</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="7r35ow4y";>9</th>
      <td>Kramer_2015</td>
      <td>Antilipidemic Drug Therapy Today and in the Future</td>
      <td>Kramer, Werner</td>
      <td>2015</td>
      <td>2015-04-24</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122375" target="_blank">PMC7122375</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26330256.0" target="_blank">26330256.0</a></td>
      <td><a href="https://doi.org/10.1007/164_2015_15" target="_blank">10.1007/164_2015_15</a></td>
      <td>7r35ow4y</td>
      <td>0.401856</td>
      <td><a href="Topic_01.html#muq3eq9v">Bumcrot_2006</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="cxxk09t2";>10</th>
      <td>Mathew_2015</td>
      <td>Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds</td>
      <td>Mathew, Shilu; Fatima, Kaneez; Fatmi, M. Qaiser; Archunan, Govindaraju; Ilyas, Muhammad; Begum, Nargis; Azhar, Esam; Damanhouri, Ghazi; Qadri, Ishtiaq</td>
      <td>2015</td>
      <td>2015-06-01</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451521" target="_blank">PMC4451521</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26030803.0" target="_blank">26030803.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0126510" target="_blank">10.1371/journal.pone.0126510</a></td>
      <td>cxxk09t2</td>
      <td>0.385385</td>
      <td></td>
      <td><a href="Topic_08.html#qhhdjgeq">Zhu_X_2015</a>, <a href="Topic_03.html#mqicryxr">Gao_M_2010</a></td>
    </tr>
    <tr>
      <th id="lgae22f8";>11</th>
      <td>Gerold_2013</td>
      <td>Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C</td>
      <td>Gerold, Gisa; Pietschmann, Thomas</td>
      <td>2013</td>
      <td>2013-10-04</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089091" target="_blank">PMC7089091</a></td>
      <td></td>
      <td><a href="https://doi.org/10.1007/s11901-013-0187-1" target="_blank">10.1007/s11901-013-0187-1</a></td>
      <td>lgae22f8</td>
      <td>0.365659</td>
      <td><a href="Topic_02.html#t2vdzppd">Jerome_2005</a>, <a href="Topic_02.html#ali14j7x">Wisskirchen_2014</a></td>
      <td><a href="Topic_02.html#33gvt7pe">Lin_K_2013</a></td>
    </tr>
    <tr>
      <th id="px1xaszl";>12</th>
      <td>Pawlotsky_2014</td>
      <td>What are the pros and cons of the use of host-targeted agents against hepatitis C?</td>
      <td>Pawlotsky, Jean-Michel</td>
      <td>2014</td>
      <td>2014-05-31</td>
      <td>PMC</td>
      <td>N</td>
      <td></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/24583032.0" target="_blank">24583032.0</a></td>
      <td><a href="https://doi.org/10.1016/j.antiviral.2014.02.008" target="_blank">10.1016/j.antiviral.2014.02.008</a></td>
      <td>px1xaszl</td>
      <td>0.363768</td>
      <td><a href="Topic_02.html#c732txfd">Shaw_2011</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="cdm39qt9";>13</th>
      <td>Prabakaran_2009</td>
      <td>Combination Therapy Using Chimeric Monoclonal Antibodies Protects Mice from Lethal H5N1 Infection and Prevents Formation of Escape Mutants</td>
      <td>Prabakaran, Mookkan; Prabhu, Nayana; He, Fang; Hongliang, Qian; Ho, Hui-Ting; Qiang, Jia; TaoMeng,; Goutama, Michael; Kwang, Jimmy</td>
      <td>2009</td>
      <td>2009-05-22</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682562" target="_blank">PMC2682562</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19478856.0" target="_blank">19478856.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0005672" target="_blank">10.1371/journal.pone.0005672</a></td>
      <td>cdm39qt9</td>
      <td>0.354864</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="40tq0fa7";>14</th>
      <td>Saylor_2009</td>
      <td>Monoclonal antibody-based therapies for microbial diseases</td>
      <td>Saylor, Carolyn; Dadachova, Ekaterina; Casadevall, Arturo</td>
      <td>2009</td>
      <td>2009-12-30</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810317" target="_blank">PMC2810317</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/20006139.0" target="_blank">20006139.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2009.09.105" target="_blank">10.1016/j.vaccine.2009.09.105</a></td>
      <td>40tq0fa7</td>
      <td>0.350002</td>
      <td><a href="Topic_15.html#s6x0igia">Dove_2004</a></td>
      <td><a href="Topic_01.html#grsv06j7">Flego_2013</a></td>
    </tr>
    <tr>
      <th id="58ta20fg";>15</th>
      <td>Van_Norman_2018</td>
      <td>Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies</td>
      <td>Van Norman, Gail A.</td>
      <td>2018</td>
      <td>2018-06-25</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058931" target="_blank">PMC6058931</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/30062226.0" target="_blank">30062226.0</a></td>
      <td><a href="https://doi.org/10.1016/j.jacbts.2018.02.001" target="_blank">10.1016/j.jacbts.2018.02.001</a></td>
      <td>58ta20fg</td>
      <td>0.344437</td>
      <td><a href="Topic_15.html#s6x0igia">Dove_2004</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="n9ptifg8";>16</th>
      <td>Hansson_2015</td>
      <td>Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection</td>
      <td>Hansson, Magnus Joakim; Moss, Steven James; Bobardt, Michael; Chatterji, Udayan; Coates, Nigel; Garcia-Rivera, Jose A; Elmér, Eskil; Kendrew, Steve; Leyssen, Pieter; Neyts, Johan; Nur-E-Alam, Mohammad; Warneck, Tony; Wilkinson, Barrie; Gallay, Philippe; Gregory, Matthew Alan</td>
      <td>2015</td>
      <td>2015-01-22</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336584" target="_blank">PMC4336584</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/25619934.0" target="_blank">25619934.0</a></td>
      <td><a href="https://doi.org/10.1016/j.chembiol.2014.10.023" target="_blank">10.1016/j.chembiol.2014.10.023</a></td>
      <td>n9ptifg8</td>
      <td>0.339165</td>
      <td></td>
      <td><a href="Topic_08.html#qhhdjgeq">Zhu_X_2015</a>, <a href="Topic_02.html#gxbrgy6g">Lee_C_2019</a></td>
    </tr>
    <tr>
      <th id="psaf2vls";>17</th>
      <td>Adriouch_2011</td>
      <td>Improved Immunological Tolerance Following Combination Therapy with CTLA-4/Ig and AAV-Mediated PD-L1/2 Muscle Gene Transfer</td>
      <td>Adriouch, Sahil; Franck, Emilie; Drouot, Laurent; Bonneau, Carole; Jolinon, Nelly; Salvetti, Anna; Boyer, Olivier</td>
      <td>2011</td>
      <td>2011-09-29</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202221" target="_blank">PMC3202221</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22046170.0" target="_blank">22046170.0</a></td>
      <td><a href="https://doi.org/10.3389/fmicb.2011.00199" target="_blank">10.3389/fmicb.2011.00199</a></td>
      <td>psaf2vls</td>
      <td>0.331378</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="12kihnp7";>18</th>
      <td>Bolken_2008</td>
      <td>Discovery and development of antiviral drugs for biodefense: Experience of a small biotechnology company</td>
      <td>Bolken, Tove C.; Hruby, Dennis E.</td>
      <td>2008</td>
      <td>2008-01-31</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972676" target="_blank">PMC2972676</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/17765333.0" target="_blank">17765333.0</a></td>
      <td><a href="https://doi.org/10.1016/j.antiviral.2007.07.003" target="_blank">10.1016/j.antiviral.2007.07.003</a></td>
      <td>12kihnp7</td>
      <td>0.317043</td>
      <td><a href="Topic_15.html#s6x0igia">Dove_2004</a></td>
      <td><a href="Topic_08.html#qhhdjgeq">Zhu_X_2015</a></td>
    </tr>
    <tr>
      <th id="rtqkvf63";>19</th>
      <td>Padberg_2015</td>
      <td>2.6 Anti-infective Agents</td>
      <td>Padberg, Stephanie</td>
      <td>2015</td>
      <td>2015-12-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150338" target="_blank">PMC7150338</a></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/b978-0-12-408078-2.00007-x" target="_blank">10.1016/b978-0-12-408078-2.00007-x</a></td>
      <td>rtqkvf63</td>
      <td>0.301302</td>
      <td></td>
      <td></td>
    </tr>
  </tbody>
</table>
</body>
</html>
